Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)

for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

研究成果: Contribution to journalComment/debate査読

抄録

In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.

本文言語英語
ページ(範囲)431-432
ページ数2
ジャーナルInternational journal of hematology
112
3
DOI
出版ステータス出版済み - 9 1 2020

All Science Journal Classification (ASJC) codes

  • Hematology

フィンガープリント 「Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy (International Journal of Hematology, (2020), 112, 3, (349-360), 10.1007/s12185-020-02911-z)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル